Freedman Financial Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-760
| Closed | -$123K | – | 5 |
|
|
2022
Q1 | $123K | Buy |
760
+102
| +16% | +$16.5K | 0.08% | 108 |
|
|
2021
Q4 | $89K | Buy |
658
+2
| +0.3% | +$271 | 0.06% | 132 |
|
|
2021
Q3 | $71K | Buy |
656
+46
| +8% | +$4.98K | 0.05% | 152 |
|
|
2021
Q2 | $69K | Buy |
610
+2
| +0.3% | +$226 | 0.05% | 151 |
|
|
2021
Q1 | $66K | Buy |
608
+2
| +0.3% | +$217 | 0.05% | 158 |
|
|
2020
Q4 | $65K | Buy |
+606
| New | +$65K | 0.06% | 144 |
|